Canada Markets closed

BriaCell Therapeutics Corp. (BCTX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
10.100.00 (0.00%)
At close: 4:00PM EST
Currency in USD

Valuation Measures

We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 1.54
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 310.72
52 Week Low 32.81
50-Day Moving Average 38.59
200-Day Moving Average 35.77

Share Statistics

Avg Vol (3 month) 31.9M
Avg Vol (10 day) 31.06M
Shares Outstanding 514.33M
Implied Shares Outstanding 6N/A
Float 811.68M
% Held by Insiders 123.64%
% Held by Institutions 143.90%
Shares Short (Sep. 14, 2021) 41.9M
Short Ratio (Sep. 14, 2021) 40.89
Short % of Float (Sep. 14, 2021) 4N/A
Short % of Shares Outstanding (Sep. 14, 2021) 412.46%
Shares Short (prior month Aug. 12, 2021) 41.64M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jan. 01, 2020
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in CAD.

Fiscal Year

Fiscal Year Ends Jul. 30, 2020
Most Recent Quarter (mrq)Apr. 29, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-34.53%
Return on Equity (ttm)32.27%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -7.29M
Net Income Avi to Common (ttm)2.12M
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)24.65M
Total Cash Per Share (mrq)1.62
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)122.44
Book Value Per Share (mrq)N/A

Cash Flow Statement

Operating Cash Flow (ttm)-7.48M
Levered Free Cash Flow (ttm)-6.8M